These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16673529)

  • 21. [Efficacy of contrykal in acute pneumonia].
    Akhvlediani IV; Kunakov IuI
    Voen Med Zh; 1991 Oct; (10):36-8, 78. PubMed ID: 11411358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery.
    Dietrich W; Ebell A; Busley R; Boulesteix AL
    Ann Thorac Surg; 2007 Oct; 84(4):1144-50. PubMed ID: 17888960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant.
    Kober BJ; Scheule AM; Voth V; Deschner N; Schmid E; Ziemer G
    Anesth Analg; 2008 Aug; 107(2):406-9. PubMed ID: 18633016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
    Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of aprotinin-specific immunoglobulin G antibodies after cardiac operations.
    Weipert J; Meisner H; Jochum M; Dietrich W
    J Thorac Cardiovasc Surg; 1997 Oct; 114(4):676-8. PubMed ID: 9338657
    [No Abstract]   [Full Text] [Related]  

  • 28. An unusual fatal reaction to a test dose of aprotinin before elective thoracoabdominal aortic aneurysm repair.
    Weil DP; Stearns JD; Watson T; Horak J
    Eur J Anaesthesiol; 2008 Apr; 25(4):346-8. PubMed ID: 18334042
    [No Abstract]   [Full Text] [Related]  

  • 29. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aprotinin and renal dysfunction after pediatric cardiac surgery.
    Székely A; Sápi E; Breuer T; Kertai MD; Bodor G; Vargha P; Szatmári A
    Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case 4-2007. Aprotinin-induced cardiovascular collapse after a negative test dose in a patient scheduled for repeat mitral valve surgery.
    Beaulieu PL; Gandhi SD; Iqbal Z; Butler EG; Almassi GH; Pagel PS; Levy JH
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):597-601. PubMed ID: 17678797
    [No Abstract]   [Full Text] [Related]  

  • 32. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.
    Gagne JJ; Griesdale DE; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):259-68. PubMed ID: 19185048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aprotinin and renal risk in cardiac surgery.
    Casati V; Galli L; D'Angelo A
    Transfusion; 2006 Dec; 46(12):2207; author reply 2209-10. PubMed ID: 17176335
    [No Abstract]   [Full Text] [Related]  

  • 34. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action.
    McEvoy MD; Reeves ST; Reves JG; Spinale FG
    Anesth Analg; 2007 Oct; 105(4):949-62. PubMed ID: 17898372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An anaphylactic reaction after primary exposure to an aprotinin test dose in a child with a severe milk allergy.
    Kaddoum RN; Chidiac EJ; Zestos MM; Rajan SD; Baraka A
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):243-4. PubMed ID: 17418739
    [No Abstract]   [Full Text] [Related]  

  • 36. Serine protease inhibitor aprotinin ameliorates renal injury in a rat model of ischemia-perfusion injury.
    Altan H; Bozkurt AK; Arslan C; Ustundag N; Konukoglu D; Koksal C
    Transplant Proc; 2009 Jun; 41(5):1512-6. PubMed ID: 19545668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Commentary on the article of Dennis T. Mangano: Aprotinin and risks in cardiac surgery].
    Bizouarn P
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):791-5. PubMed ID: 16839738
    [No Abstract]   [Full Text] [Related]  

  • 38. Case 1-2008. One institution's decreasing use of aprotinin during cardiac surgery in 2006.
    Strouch ZY; Chaney MA; Augoustides JG; Spiess BD
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):139-46. PubMed ID: 18249349
    [No Abstract]   [Full Text] [Related]  

  • 39. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Beattie WS; Karkouti K
    Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
    [No Abstract]   [Full Text] [Related]  

  • 40. Aprotinin use during cardiac surgery: a new or continuing controversy?
    Hogue CW; London MJ
    Anesth Analg; 2006 Nov; 103(5):1067-70. PubMed ID: 17056933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.